Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SH3BP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | UNC13D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | FRAT2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SGK494 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ABCD4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MRPS18A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | LRFN2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ACOT9 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | FAM60A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ADAMTSL2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |